13D Filing: Aisling Capital III LP and Loxo Oncology Inc. (LOXO)

Page 13 of 13

Page 13 of 13 – SEC Filing

CUSIP No. 548862101
SCHEDULE 13D
Page 13 of 13

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: November 28, 2017
AISLING CAPITAL III, LP
By:
Aisling Capital Partners III, LP
General Partner
By:
Aisling Capital Partners III LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
AISLING CAPITAL PARTNERS III, LP
By:
Aisling Capital Partners III LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
AISLING CAPITAL PARTNERS III LLC
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
/s/ Steven Elms
Steven Elms
/s/ Dennis Purcell
Dennis Purcell
/s/ Andrew Schiff
Andrew Schiff
Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Loxo Oncology Inc. (NASDAQ:LOXO)

Page 13 of 13